Providing safe animal products is a universal problem. KAKETSUKEN worked on the development of vaccines against hog cholera, fowl pox, and Newcastle disease among others during the earliest days of livestock farming in Japan, playing an important role in the prevention of acute infectious diseases. However, in the midst of an increase in large-scale livestock farms and greater international competition, demand has increased for vaccines for chronic infectious diseases at lower cost while reducing labor. In addition, with the improvement of public awareness about health, the demand for safe meats and eggs increased, and needs shifted from medical treatment with antibiotics to prevention with vaccines.

Responding to such demands, KAKETSUKEN succeeded in the development of Oilvax, Japan's first combined oil-adjuvanted vaccine for fowl, which drastically prolonged the duration of protection with humoral immunity. To meet the market's demands for convenience, a large number of polyvalent vaccines is important; so far 10 different products as the Oilvax product line have been launched and two examples are Oilvax 7 which heads the list of combination vaccines and fowl salmonella bivalent vaccine which is also effective for preventing food poisoning in humans.

Vaccines for animals cover a fairly broad spectrum including those for pigs, cattle, horses, dogs, and cats, in addition to those for fowl. We have recently put a great deal of effort into product development for pigs. In addition to our core combination vaccines against porcine atrophic rhinitis (AR), mycoplasmal pneumoniae of swine, transmissible gastroenteritis of swine (TGE)/porcine epidemic diarrhea (PED), we have also been pursuing the development of the Suimmugen line of drugs with a focus on a combined vaccine against porcine pleuropneumonia, swine erysipelas, and porcine enterohemorrhagic Escherichia coli among others. In addition to the above, the three-way vaccine against bovine viral congenital abnormality, Akabane disease vaccine, and the rabies vaccine for dogs are available, and a vaccine for horses was also developed. The Aso Laboratory supports a system that has taken all possible measures to supply high quality vaccines through breeding various specific pathogen free (SPF) animals for vaccine materials and quality control tests.

The need for high quality products for use with animals increases year by year. In order to provide superior high quality products with greater efficacy, KAKETSUKEN will continue to contribute to the stable supply and hygienic improvement of livestock products with the most modern facilities conforming to Good Manufacturing Practice (GMP) standards.